Autor: |
Vishnu KS; Department of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India., Dineshbabu S; Department of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India., Kadhiravan T; Department of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. |
Jazyk: |
angličtina |
Zdroj: |
The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2024 Sep 10; Vol. 111 (5), pp. 1142-1144. Date of Electronic Publication: 2024 Sep 10 (Print Publication: 2024). |
DOI: |
10.4269/ajtmh.24-0374 |
Abstrakt: |
Limited data indicate that snakebite survivors have persistent musculoskeletal disability. We assessed the pain and functional disability at hospital discharge and after 3 months in 47 patients treated for snakebite envenoming and with at least a specified amount of local swelling at the time of hospital discharge, using the numerical pain rating scale and the Patient-Specific Functional Scale (PSFS). Russell's viper was the most common biting snake species identified. At hospital discharge, the median pain score was 2 (0-3); 9 (19%) patients reported mild persisting pain at 3 months. The median PSFS score at hospital discharge was 3.7 (3.3-4.0), which improved to 8.3 (6.3-9.0) on follow-up (P <0.001); 32 (68%) patients had a PSFS score of 8.9 or below on follow-up. We conclude that snakebite envenoming could be associated with persisting functional disability at 3 months even in the absence of local complications such as skin necrosis and compartment syndrome. |
Databáze: |
MEDLINE |
Externí odkaz: |
|